UPDATE 1-Mylan, U.S. finalize $465 million EpiPen settlement

BOSTON, Aug 17 (Reuters) – Mylan NV has finalized a$465 million settlement with the U.S. Justice Department,resolving claims it overcharged the government for its EpiPenemergency allergy treatment, which became the center of afirestorm over price increases.
The post UPDATE 1-Mylan, U.S. finalize $465 million EpiPen settlement appeared first on RocketNews | Top News Stories From Around the Globe.